We are live on ! Find out more
CO

Global Cord Blood Corporation

Delisted

CO was delisted on the 23rd of September, 2022.

28 hedge funds and large institutions have $26.8M invested in Global Cord Blood Corporation in 2020 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 2828 (0)

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

0% less capital invested

Capital invested by funds: $26.9M → $26.8M (-$49.5K)

11% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 9

88% less call options, than puts

Call options by funds: $5K | Put options by funds: $41K

Holders
28
Holders Change
Holders Change %
0%
% of All Funds
0.5%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
8
Reduced
9
Closed
3
Calls
$5K
Puts
$41K
Net Calls
-$36K
Net Calls Change
-$34K
Name Holding Trade Value Shares
Change
Change in
Stake
SPIA
26
Steward Partners Investment Advisory
New York
$1K
PI
27
PEAK6 Investments
Illinois
-$183K -51,814 Closed
MWA
28
Marshall Wace Asia
Hong Kong
-$165K -46,613 Closed
Group One Trading
29
Group One Trading
Illinois
-$7K -2,000 Closed

CO Hedge Fund Activity: Q4 2020 in Review

28 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Global Cord Blood Corporation (CO) for Q4 2020, worth a combined $26.8M — down 0.18% from $26.9M a quarter earlier.

Fund positioning in CO was balanced in Q4 2020: 3 funds opened new positions, 3 closed out, 8 added to existing stakes and 9 trimmed.

The largest buyer was Squarepoint, opening a new position worth an estimated $54.2K. The largest seller was Rock Springs Capital Management, cutting an estimated $498K.

  • 28 institutional investors held Global Cord Blood Corporation (CO) as of Q4 2020, unchanged from Q3 2020.
  • Funds reported $26.8M of Global Cord Blood Corporation stock for Q4 2020, down 0.18% quarter-over-quarter.
  • 3 funds opened new Global Cord Blood Corporation positions in Q4 2020 and 3 closed out, a net change of 0 holders.
  • The largest Global Cord Blood Corporation buyer in Q4 2020 was Squarepoint, an estimated $54.2K added.
  • The largest Global Cord Blood Corporation seller in Q4 2020 was Rock Springs Capital Management, an estimated $498K sold.

Based on aggregated 13F filings for Q4 2020.